复发性耐药性妊娠滋养细胞肿瘤的诊治

doi:10.7504/fk2015020110

摘要/Abstract

摘要：

尽管妊娠滋养细胞肿瘤对化疗高度敏感，但仍有10%患者化疗时耐药，或治疗后复发。耐药和复发后患者的治疗原则为化疗为主、辅以手术等的综合治疗。尽管补救化疗方案较多，但迄今尚无一个明确的高效、低毒的补救化疗方案。

Abstract:

Abstract:Gestational trophoblastic neoplasia (GTN) is a highly curable group of pregnancy-related tumours; however, approximately 10% of GTN tumours will be resistant to, or will relapse after, initial chemotherapy. These resistant and relapsed lesions will require salvage chemotherapy with or without surgery. Various salvage regimens are used worldwide. It is unclear which regimens are the most effective and the least toxic.

Key words: gestational trophoblastic neoplasia, chemotherapy, resistant；recurrent

中图分类号:

R737.3

吕卫国. 复发性耐药性妊娠滋养细胞肿瘤的诊治[J]. 中国实用妇科与产科杂志, DOI: 10.7504/fk2015020110.

Lü Wei-guo.. Diagnosis and management of or recurrent resistant gestational trophoblastic neoplasia.[J]. Acta Metallurgica Sinica, DOI: 10.7504/fk2015020110.

参考文献

［1］   Ngu SF,Chan KKL.Management of chemoresistant and quiescent gestational trophoblastic disease［J］. Curr Obstet Gynecol Rep,2014，3:84-90.

［2］   Mcneish IA,Strickland S,Holden L,et al.Low-risk persistent gestational trophoblastic disease:outcome after initial treatment with low-dose methotrexate and folinic acid from 1992 to 2000［J］. J Clin Oncol，2002，20:1838-1844.

［3］   Evan AC Jr,Schlaerh J,Gaddis O,et al.Gestational trophoblastic disease metastatic to the central nervous systenm［J］.Gynecol Oncol,1995，59:226-230.

［4］   Covens A,Filiaci VL,Burger RA,et al. Phase II trial of pulse dactinomycin as salvage therapy for failed low-risk gestational trophoblastic neoplasia:a Gynecologic Oncology Group study［J］ .Cancer, 2006，107: 1280-1286.

［5］   Sarah N,Michael J,Seckl.Gestational trophoblastic neoplasia mangement:an update［J］.Curr Opin Oncol,2007,19:486-491.

［6］   Powles T, Savage PM,Stebbing J, et al. A comparison of patients with relapsed and chemo-refractory gestational trophoblastic neoplasia［J］. Br J Cancer,2007,96(5):732-737.

［7］    Ngan HY, Kohorn EI, Cole LA, et al. Trophoblastic disease［J］. Int J Gynaecol Obstet，2012，119 Suppl2:S130-136.

［8］    Newlands ES,Mulholland PJ,Holden L,et al.Etoposide and cisplatin/etoposide,methotrexate,and actinomycin D(EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine chemotherapy and patients presenting with metastatic placental site trophoblastic tumors［J］.J Clin Oncol,2000，18:854-859.

［9］    Mao Y,Wan X,Lv W,et al.Relapsed or refractory gestational trophoblastic neoplasia treated with the etoposide and cisplatin/etoposide,methotrexate,and actinomycin D(EP-EMA) regimen［J］.Int J Gynaecol Obstet,2007，98(1):44-47

［10］    Wang J,Sebire SNJ,Lindsay I,et al.Salvage chemotherapy of relapsed or high-risk gestational trophoblastic neoplasia (GTN) with paclitaxel/cisplatin alternating with paclitaxel/etoposide (TP/TE) ［J］.Ann Oncol,2008，19: 1578-1583.

（2014-11-16收稿）

[1]	吕卫国, 陈丽莉. 重视妊娠滋养细胞肿瘤的规范化治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 673-675.
[2]	彭美莲, 林开武, 翁宗杰, 吴齐斌, 孙蓬明. 妊娠滋养细胞疾病的影像学特征及意义[J]. 中国实用妇科与产科杂志, 2022, 38(7): 680-684.
[3]	刘晓梅, 李秀琴. 低危妊娠滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 687-691.
[4]	李克敏, 尹如铁. 高危妊娠滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 691-693.
[5]	程红燕, 向阳. 妊娠滋养细胞肿瘤的免疫治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 693-696.
[6]	王芬芬, 鲍可纯, 程晓东. 特殊病理类型妊娠滋养细胞肿瘤的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(7): 696-701.
[7]	奚玲, 孙玥. 妊娠滋养细胞肿瘤生育力保留策略[J]. 中国实用妇科与产科杂志, 2022, 38(7): 701-704.
[8]	郎景和. 关于妇科复发性疾病与疑难性疾病的若干问题[J]. 中国实用妇科与产科杂志, 2022, 38(5): 481-483.
[9]	张师前. 聚焦关键少数，做好塔尖工作[J]. 中国实用妇科与产科杂志, 2022, 38(5): 484-486.
[10]	王辰, 王颖梅, 薛凤霞. 复发性外阴阴道假丝酵母菌病的预防与治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 487-491.
[11]	彭超, 周应芳. 复发性卵巢子宫内膜异位症的管理[J]. 中国实用妇科与产科杂志, 2022, 38(5): 491-495.
[12]	鲁永鲜. 盆腔器官脱垂手术复发的预防与治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 495-499.
[13]	谢鹏, 郭秋芬, 张师前. 复发性子宫颈癌的综合治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 499-503.
[14]	李一帆, 李宁, 吴令英. 铂耐药复发卵巢上皮性癌的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 503-507.
[15]	徐兴远, 王丹波. 复发性子宫内膜癌的治疗[J]. 中国实用妇科与产科杂志, 2022, 38(5): 507-511.